Women's Health and the Cloning Debate
By Elayne Clift,
Womens Feature Service
| 09. 16. 2002
American feminists and women's health activists are debating on the
difficult issue of human cloning and stem cell research. Human cloning
involves creating embryos with the intent of implanting them in women
to produce children. In therapeutic cloning on the other hand, genetic
material from a body cell is inserted into an egg cell, replacing the
nucleus. As the cell begins to divide, scientists believe stem cells
can be extracted and grown into tissue or organs. Thus, a kind of
'regenerative medicine' gives people access to therapies derived from
their own cells.
Last year, the
Republican-controlled House of Representatives in the US Congress
passed a bill banning all human cloning, a measure President Bush
supports. The bill, introduced by Sam Brownback, a Kansas Republican
who has been called "the torchbearer of the Christian Right", called
for a total ban on human cloning, which would also preclude cloning
embryonic stem cells for research purposes, or 'therapeutic cloning'.
In
May 2002, the Senate countered with its own legislation designed to
foster scientific research. Their "Human Cloning Prohibition Act of
2002" would prohibit...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...